LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-25
DOI
10.1186/s13046-021-01844-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ROR2 promotes the epithelial‐mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer
- (2020) Jin Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
- (2020) Weiwei Sheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas
- (2020) Jiehua He et al. Molecular Cancer
- DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
- (2020) Chenfei Lu et al. Molecular Cancer
- A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway
- (2020) Khayal Al-Khayal et al. BMC CANCER
- Cellular senescence promotes skin carcinogenesis through p38MAPK and p44/p42MAPK signaling
- (2020) Fatouma Alimirah et al. CANCER RESEARCH
- LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells
- (2020) Shuyao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age
- (2020) Rikhia Chakraborty et al. Cold Spring Harbor Perspectives in Medicine
- MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC
- (2020) Derek A. Franklin et al. JCI Insight
- Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
- (2019) Huaying Dong et al. Molecular Cancer
- High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia
- (2019) Mingshan Niu et al. Cancer Cell International
- Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
- (2019) Yiran Liang et al. SEMINARS IN CANCER BIOLOGY
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- LncRNA SPRY4‐IT1 regulates breast cancer cell stemness through competitively binding miR‐6882‐3p with TCF7L2
- (2019) Xinyue Song et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Long Noncoding RNAs and Repetitive Elements: Junk or Intimate Evolutionary Partners?
- (2019) Hyunmin Lee et al. TRENDS IN GENETICS
- LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma
- (2018) Yunxing Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway
- (2018) Wei Song et al. ONCOLOGY RESEARCH
- PlncRNA-1 is overexpressed in retinoblastoma and regulates retinoblastoma cell proliferation and motility through modulating CBR3
- (2018) Shuna Wang et al. IUBMB LIFE
- A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer
- (2018) Grant R. Howard et al. Scientific Reports
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression
- (2016) Ziyu Fang et al. CANCER LETTERS
- Long non-coding RNA: A newly deciphered “code” in prostate cancer
- (2016) Ailin Zhang et al. CANCER LETTERS
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
- (2016) Yashar S. Niknafs et al. Nature Communications
- LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
- (2015) X Xue et al. ONCOGENE
- Upregulation of the Long Non-coding RNA PlncRNA-1 Promotes Esophageal Squamous Carcinoma Cell Proliferation and Correlates with Advanced Clinical Stage
- (2013) Chun-Mei Wang et al. DIGESTIVE DISEASES AND SCIENCES
- The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor
- (2012) Zilian Cui et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Labeled microRNA pull-down assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs
- (2009) Ren-Jun Hsu et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search